Serglycin Cooperates with the Unfolded Protein Response Pathway and Inflammation to Drive Glioblastoma Cell Survival
Cells · 09.04.2026 · 15 (8) · 660
DOI: 10.3390/cells15080660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 09.04.2026. Verfasst von Eleftherios N Athanasopoulos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras,…. Hauptthemen laut MEDLINE: Glioblastoma, Unfolded Protein Response, Vesicular Transport Proteins, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Serglycin (SRGN) has been found overexpressed and secreted in glioblastoma (GBM), associated with tumorigenic signaling and poor prognosis. In this study, we aimed to elucidate the involvement of SRGN in the unfolded protein response (UPR), an oncogenic signaling pathway implicated in protein recycling and cell fate. Herein, we developed stably transduced LN-18shSCR GBM cells, expressing high levels of SRGN, and SRGN-depleted LN-18shSRGN cells. We observed significantly attenuated expression and activity of all UPR mediators upon SRGN suppression, in particular PERK, IRE1, ATF6 and downstream effectors. SRGN-expressing cells possessed a constitutively active UPR, as indicated by its active phosphorylation status and accumulated pool of nuclear ATF4 in LN-18shSCR cells. Constitutive activation of the caspase-dependent apoptotic pathway was apparent in LN-18shSRGN cells. Induction of endoplasmic reticulum (ER) stress pointed out that LN-18shSRGN cells were predisposed to ER stress-associated cell death, whereas LN-18shSCR cells activated adaptive UPR signaling and displayed resistance to apoptosis. The evaluation of TLRs, TNFRs, ILs and NF-kB also underscored that SRGN is essential for their expression and active inflammatory signaling. We concluded that SRGN-expressing cells acquire a pro-survival UPR mechanism, highlighting the novel regulatory role of SRGN in the adaptation and survival of GBM cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece.
- Cardiovascular Research Translational Studies, Clinical Sciences Malmö, Lund University, 22100 Lund, Sweden.
- Hematology Division, Department of Internal Medicine, University Hospital of Patras, University of Patras, 26504 Patras, Greece.
ORCID-Profile: Chrysostomi Gialeli, Achilleas D Theocharis
Zitieren
APA
Athanasopoulos, E. N., Gialeli, C., Natsiou, A., Manou, D., Labropoulou, V. T., & Theocharis, A. D. (2026). Serglycin Cooperates with the Unfolded Protein Response Pathway and Inflammation to Drive Glioblastoma Cell Survival. Cells, 15(8), 660. https://doi.org/10.3390/cells15080660
Vancouver
Athanasopoulos EN, Gialeli C, Natsiou A, Manou D, Labropoulou VT, Theocharis AD. Serglycin Cooperates with the Unfolded Protein Response Pathway and Inflammation to Drive Glioblastoma Cell Survival. Cells. 2026;15(8):660. doi:10.3390/cells15080660
BibTeX
@article{Athanasopoulos2026,
author = {Athanasopoulos, Eleftherios N and Gialeli, Chrysostomi and Natsiou, Angeliki and Manou, Dimitra and Labropoulou, Vassiliki T and Theocharis, Achilleas D},
title = {Serglycin Cooperates with the Unfolded Protein Response Pathway and Inflammation to Drive Glioblastoma Cell Survival},
journal = {Cells},
year = {2026},
volume = {15},
number = {8},
pages = {660},
doi = {10.3390/cells15080660}
}
EUVIMED